We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Articles

Results 1 to 5 of 20
Most popular |Most recent


DOJ revises its guidance on corporate compliance programs

USA - May 2 2019 This week, Assistant Attorney General Brian A. Benczkowski announced a significant rewrite of the Department of Justice’s (DOJ) guidance document...

Angela J. Crawford, Grayson D. Stratton, Elan Gershoni.

Life Sciences: Compliance and enforcement in the USA

USA, Global - November 14 2018 A structured guide to compliance and dishonest practices in the USA...

James N. Czaban, George M. Karavetsos, Andrew J. Hoffman, Melissa Gierach, Eric Paul Christofferson, Anna Spencer, Raymond M. Williams, Jessica Wilson, Rebecca Jones McKnight.

Pharmacovigilance in the USA

USA, Global - November 14 2018 A structured guide to Pharmacovigilance in the USA...

James N. Czaban, George M. Karavetsos, Andrew J. Hoffman, Melissa Gierach, Eric Paul Christofferson, Anna Spencer, Raymond M. Williams, Jessica Wilson, Rebecca Jones McKnight.

Life Sciences: product regulation and liability in the USA

USA, Global - November 14 2018 A structured guide to product regulation and liability laws in the USA...

James N. Czaban, George M. Karavetsos, Andrew J. Hoffman, Melissa Gierach, Eric Paul Christofferson, Anna Spencer, Raymond M. Williams, Jessica Wilson, Rebecca Jones McKnight.

Clinical trials in the USA

USA, Global - November 14 2018 A structured guide to clinical trials in the USA...

James N. Czaban, George M. Karavetsos, Andrew J. Hoffman, Melissa Gierach, Eric Paul Christofferson, Anna Spencer, Raymond M. Williams, Jessica Wilson, Rebecca Jones McKnight.